A research-backed review

Kava for Anxiety: Can It Quiet Worry and Help You Feel Calmer?

Some people feel calmer with kava. The research offers reasons for interest, alongside important conflicting results.

A Nukava bottle beside a steaming mug and an open book in warm window light.
Updated

Commercial disclosure: this guide is written by Nukava’s founders. Nukava sells kava. This is education, not medical advice; the research discussed does not establish that Nukava products treat these conditions.

Can kava reduce anxiety symptoms?

Kava may ease anxiety for some people, but results are inconsistent. Several smaller trials were positive; a larger, longer trial found no advantage over placebo. It is more reasonable to expect possible calm than dependable treatment of an anxiety disorder.

In this guide · Jump to a section

Kava and Anxiety: Symptoms, Context and Possible Effects

Everyday Worry and Anxiety Disorders

An anxious afternoon, persistent generalized worry and sudden panic are different experiences. A relaxing evening can matter, while a treatment for an anxiety disorder needs to improve daily functioning over time. Being able to sleep, participate and handle ordinary responsibilities is a more useful goal than simply feeling an effect.

Kava’s Social Traditions and Modern Extracts

Kava has a long history in Pacific social and ceremonial settings. Preparing a drink and sharing unhurried conversation can also shape the experience. Modern clinical trials usually test specific extracts under controlled conditions, so their results cannot be assumed for every root beverage, tincture or commercial blend.

How Kavalactones May Affect Anxiety

Laboratory research on kavalactones identifies effects on nervous-system signaling, including GABA-related mechanisms. That makes anxiety a reasonable research question. Laboratory activity does not tell us how much relief a person will notice, how long it will last, or whether a particular product will reproduce a trial’s result.

Kava for Anxiety: Key Human Studies

These studies show the main tension in the evidence: promising smaller results alongside substantial null findings.

Evidence reviewed for this guide
SourceEvidenceDesignWhat it foundWhat to keep in mind
Volz & Kieser, 1997
Supports

Claim: Kava can reduce anxiety symptoms in adults.

This longer placebo comparison reported anxiety improvement favoring kava; its older mixed-diagnosis population limits generalization.

101 outpatients; placebo-controlled study over 25 weeks.Anxiety ratings favored kava from week eight.Older, mixed-diagnosis population; not all anxiety conditions are interchangeable.
Multicenter anxiety trial, 2003
Neutral

Claim: Kava can reduce anxiety symptoms in adults.

A nonsignificant primary endpoint and favorable secondary adjusted analysis give mixed evidence, sensitive to analytic choices.

141 patients; four-week placebo-controlled trial.Primary endpoint was not significant; a secondary adjusted analysis favored kava.The choice of analysis changes the conclusion.
Sarris et al., 2013
Supports

Claim: Kava can reduce anxiety symptoms in adults.

Anxiety scores and remission favored kava in this small randomized trial; selection and missing-data methods limit generalization.

58 randomized adults with GAD; six weeks.Anxiety improved more with kava; remission was 26% versus 6%.Small trial excluded initial placebo responders.
Sarris et al., 2020
Neutral

Claim: Kava can reduce anxiety symptoms in adults.

The larger trial detected no significant anxiety benefit. This null finding limits confidence but does not establish universal ineffectiveness.

171 adults with GAD; 16-week placebo comparison.No significant anxiety or remission advantage.Substantial withdrawals, but the negative finding cannot be dismissed.

Sources accessed October 12, 2026. This is a focused review of the linked sources, not an exhaustive search of every kava study.

How to Interpret the Anxiety Research

Why the Larger Anxiety Trials Disagree

The 2013 trial offers a concrete positive result, not just a reputation for relaxation. However, its small, selected sample leaves uncertainty about how broadly the result applies. The larger 2020 trial tested diagnosed generalized anxiety disorder for longer and did not confirm the benefit. Different preparation and design details may help explain disagreement; they do not establish that the unfavorable result is irrelevant.

What Older Anxiety Studies Add

The 25-week study makes it inaccurate to say all positive evidence came from a few days of use. Yet older studies often combined different anxiety presentations. The 2003 multicenter trial also illustrates why a favorable secondary analysis should not replace a nonsignificant primary result. Across this literature, trial quality and the question being tested matter more than simply counting positive papers.

Anxiety Relief and Everyday Functioning

A useful change might be less intrusive worry, easier conversation or better participation in normal life. Those outcomes differ from a brief pleasant sensation. If anxiety repeatedly restricts daily life, established care remains relevant even when kava feels helpful. A drink should not become the only way someone feels able to manage an ordinary situation; the evidence does not show that it replaces skills, support or treatment.

Personal Experiences With Kava for Anxiety

These accounts describe calmer thoughts, easier participation, unwanted anxiety and next-day tradeoffs. They preserve the different products and circumstances people reported, rather than treating every feeling of relief as the same outcome. Each is an attributed personal report, not a measure of how often kava works.

Calm that continued into the next day

wormwood described substantial relief from longstanding anxiety with daily Boroguru, including feeling calmer the following day. The post describes an ongoing personal routine, without a comparison group or independently measured symptom change.

Read the original account →

Evening relief with inconsistent next mornings

sɥɐʞɐs found evening relief, but next mornings varied between calm, haziness and slightly greater anxiety. Immediate relaxation and next-day functioning did not always move in the same direction.

Read the original account →

Weekend calm with a limit around panic

Inglingian reported happier, calmer thoughts during recreational weekend use, but said it did not prevent panic during a bad moment. Self-reported generalized anxiety; also described less nervousness when playing live music.

Read the original account →

Fewer intrusive thoughts, with nausea and off-day irritability

This contributor reported muscle relaxation, fewer intrusive thoughts and several hours of stronger effects, followed by milder calm. Too much on an empty stomach caused nausea; missing a usual day could bring irritability. They described bad anxiety and chronic pain, with CBD and occasional THC also in the picture. Their reported pattern was four days of use followed by three days off.

Read the original account →

An anxious first trial instead of social ease

Ratfish felt more anxious and unable to socialize after a first trial of Taveuni Secret. Preparation difficulties and an uncertain portion complicate the account. It still challenges the assumption that an unfamiliar kava experience always feels calming.

Read the original account →

Anxiety relief alongside sobriety

wraithnix described substantial anxiety relief and help staying sober. In a follow-up, they named Fiji Vanua Vanuatu prepared in an AluBall, while noting other products had been disappointing. Anxiety relief and sobriety were described together; duration and diagnosis were not supplied.

Read the original account →

Other Approaches to Anxiety Relief

The best comparison depends on whether the goal is a relaxing occasion or relief from persistent impairment.

ApproachEvidence & rolePractical tradeoffs
Cognitive behavioral therapyAddresses worry, avoidance, and responses to anxiety. SourceRequires practice and access to care; aims beyond the hours after a drink.
Clinician-selected medicationEstablished option when anxiety causes persistent impairment. SourceChoice, onset, side effects, and follow-up depend on the medicine and person.
A planned wind-down routineProvides an occasion for relaxation without promising treatment. SourceCan complement care but may be insufficient for an anxiety disorder.

What to Expect From Kava for Anxiety

Kava’s anxiety reputation has a basis in human research, but the full picture is mixed. Possible calm is a defensible expectation; dependable anxiety-disorder treatment is not established. The most useful result is a meaningful improvement in everyday life that lasts beyond the drinking occasion.

Questions About Kava and Anxiety

Open a question for the longer answer.

Does kava work immediately?

Some people notice calm during a session, but an acute laboratory study found no anxiety benefit. The clinical trials do not establish a guaranteed rapid response.

Is it better supported for generalized anxiety or panic?

Generalized anxiety has more direct research. That evidence should not be transferred to panic attacks, which involve a different question and much thinner specific evidence.

Can I assume a beverage matches a trial extract?

No. Extraction, composition and exposure differ. A positive extract study does not demonstrate the effect of every drink or of Nukava products.

Can I combine it with anxiety medication?

Do not infer compatibility from a testimonial. Kava can interact with medicines; review the specific combination with a clinician. Avoid combining it with alcohol or other sedating substances.

What does the 6/10 evidence score mean?

This score is our editorial assessment of the evidence that kava may be useful for this specific purpose, considering its relevance, quality and consistency. It is not a measure of actual usefulness for an individual, a validated clinical scale, a success rate or your probability of benefit. Less evidence does not mean less personal benefit: some people may find kava useful even where research is limited. Personal benefit, however, does not establish effectiveness for everyone.